Sinovac Biotech, Ltd (SVA)
Sinovac Biotech, Ltd (SVA) is a Chinese biopharmaceutical company focused on the development, manufacturing, and commercialization of vaccines for infectious diseases. Founded in 2001, Sinovac primarily produces vaccines for hepatitis A and B, influenza, and other viral illnesses. The company has gained global recognition for its COVID-19 vaccine, CoronaVac, which has been used in numerous countries worldwide. Sinovac operates research and manufacturing facilities in China, and its products are distributed internationally.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 7, 2025 | $55.00 | 2025-07-08 | 2025-05-23 |
Dividends Summary
- Sinovac Biotech, Ltd has issued 1 dividend payments over the past 0 years
- The most recent dividend was paid 92 days ago, on July 7, 2025
- The highest dividend payed out to investors during this period was $55.00 per share
- The average dividend paid during this period was $55.00 per share.
Company News
Sinovac Biotech Ltd. (NASDAQ: SVA) is facing a crisis as its external auditor has resigned, leading to a delay in filing its annual report with the SEC. The company's current board is reviewing actions taken by the former board, causing uncertainty and disruption to the company's operations and governance.
Upgrades For Algonquin Power & Utilities Corp (NYSE:AQN), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Algonquin Power showed an EPS of $0.11, compared to $0.15 from the year-ago quarter. The current stock performance of Algonquin Power shows a 52-week-high of $16.01 and a 52-week-low of $6.41. Mor...
They're winning when it comes to orders.